Mood Disorders News

Anhedonia severity differed across various disorders, according to results of a systematic review and meta-analysis published in JAMA Network Open.

Healio Psychiatry has compiled a list of its five most-viewed stories in August.

Researchers have identified several actionable targets for depression prevention, according to results of an exposure-wide and Mendelian randomization study published in American Journal of Psychiatry.

Cannabidiol appeared to increase cerebral blood flow to brain regions involved in memory processing, according to results of an MRI study published in Journal of Psychopharmacology.

Magnetic seizure therapy appeared to decrease suicidality among patients with treatment-resistant depression, according to results of a nonrandomized controlled trial published in JAMA Network Open.

Digital cognitive behavioral therapy for treating insomnia may also help alleviate depressive symptoms, according to study results published in Journal of Sleep Research.

Ketamine dose and blood level appeared closely related, and both were significantly associated with antidepressant benefit, according to results of a randomized clinical trial published in JAMA Network Open.

People with depression were at increased risk for cannabis use, according to results of a repeated cross-sectional study published in JAMA Network Open.

Approximately 20% of those with depression who did not respond to an SSRI remitted, and more than half saw no real benefit by switching to another monoaminergic agent, according to study results published in Journal of Clinical Psychiatry.

Certain antidepressants appeared associated with specific birth defects, according to study results published in JAMA Psychiatry.